Literature DB >> 15369753

The impact of hemolysis on Ortho-Clinical Diagnostic's ECi and Roche's elecsys immunoassay systems.

J A Snyder1, M W Rogers, M S King, J C Phillips, J F Chapman, C A Hammett-Stabler.   

Abstract

BACKGROUND: Hemolysis is regularly encountered in clinical specimens and often interferes with a variety of laboratory test methods. Although not widely recognized, immunoassays based on nonisotopic detection systems can also be affected by hemolysis. For this reason, we investigated the effect of differing amounts of hemolysis across a range of values for several immunoassays on the Ortho-Clinical Diagnostics ECi and Roche Elecsys platforms.
METHODS: Hemolysate was prepared from whole blood and spiked at varying concentrations into pooled patient serum samples for different analytes.
RESULTS: Out of the 21 analytes tested, six (28.6%) exhibited significant increases or decreases in measured concentrations with increasing amounts of hemolysis.
CONCLUSIONS: Although immunoassays are generally thought to be impervious to hemolysis interference, hemolysis can interfere in immunoassay testing platforms. For these reasons, we recommend that laboratories conduct hemolysis interference studies for all laboratory test protocols.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15369753     DOI: 10.1016/j.cccn.2004.05.017

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  10 in total

Review 1.  Pre-analytic variability in cardiovascular biomarker testing.

Authors:  Roberto Cemin; Massimo Daves
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

2.  Cardiospecificity of the 3rd generation cardiac troponin T assay during and after a 216 km ultra-endurance marathon run in Death Valley.

Authors:  H J Roth; R M Leithäuser; H Doppelmayr; M Doppelmayr; H Finkernagel; S P von Duvillard; S Korff; H A Katus; Evangelos Giannitsis; R Beneke
Journal:  Clin Res Cardiol       Date:  2007-04-26       Impact factor: 5.460

Review 3.  Effectiveness of practices to reduce blood sample hemolysis in EDs: a laboratory medicine best practices systematic review and meta-analysis.

Authors:  Nicholas J Heyer; James H Derzon; Linda Winges; Colleen Shaw; Diana Mass; Susan R Snyder; Paul Epner; James H Nichols; Julie A Gayken; Dennis Ernst; Edward B Liebow
Journal:  Clin Biochem       Date:  2012-09       Impact factor: 3.281

4.  Ephrin-A5 regulates inter-male aggression in mice.

Authors:  Michal Sheleg; Carrie L Yochum; Jason R Richardson; George C Wagner; Renping Zhou
Journal:  Behav Brain Res       Date:  2015-03-06       Impact factor: 3.332

5.  Interference of in vitro hemolysis complete blood count.

Authors:  Gabriela de Jonge; Talita L Dos Santos; Bruno R Cruz; Mackelly Simionatto; Jeanine I M Bittencourt; Everson A Krum; Mariane F Moss; Danielle Cristyane K Borato
Journal:  J Clin Lab Anal       Date:  2018-02-03       Impact factor: 2.352

6.  Analysis of 4 cases of children with false-positive results of novel coronavirus-specific antibody.

Authors:  Shuzhi Dai; Jingjing Li; Jing Li; Long Li; Lin Shi; Ling Cao; Xuemei Zhong; Weijie Liu; Ying Wang; Lijuan Ma
Journal:  BMC Pediatr       Date:  2022-06-28       Impact factor: 2.567

7.  Interpretation of hormone levels in older patients: points for consideration.

Authors:  Krystyna Sztefko; Patrycja Szybowska
Journal:  Int J Endocrinol       Date:  2012-05-14       Impact factor: 3.257

8.  Cortisol level and suicidal risk.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2018-08-24

Review 9.  The Utility of Specific Antibodies Against SARS-CoV-2 in Laboratory Diagnosis.

Authors:  Yu Fu; Yunbao Pan; Zhiqiang Li; Yirong Li
Journal:  Front Microbiol       Date:  2021-01-13       Impact factor: 5.640

10.  Effect of heamolysis on prostate-specific antigen.

Authors:  Hasan S Sağlam; Osman Köse; Fatma Ozdemir; Oztuğ Adsan
Journal:  ISRN Urol       Date:  2012-12-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.